Biotech entity

U.S. Department of Justice

government

Of the tracked stories, 1 of 2 also mention CalMatters, the most common co-covered peer. They are less corroborated than the beat average, carrying 1.5 original sources each against 8.1 for the same window. Across a 10-day span, the pace is roughly 1.4 stories per week.

Last mentioned: Jul 14, 2026

Entity pulse

Recent coverage · U.S. Department of Justice

2 stories
8.5 avg impact
50% positive
50% negative

Coverage balance Balanced directional read. Positive and negative coverage are within 0 percentage points.

  • 50% positive
  • 50% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about U.S. Department of Justice

Of the tracked stories, 1 of 2 also mention CalMatters, the most common co-covered peer. They are less corroborated than the beat average, carrying 1.5 original sources each against 8.1 for the same window. Across a 10-day span, the pace is roughly 1.4 stories per week. The 8.5 average consequence score is above the beat benchmark of 6.9 in the same window. The clearest coverage concentration is fda-approval: 1 of 2 stories, with the rest divided among 1 other category. U.S. Department of Justice appears in 2 tracked Biotech stories published from July 12, 2026 through July 21, 2026.

Stories tracked
2
Per week
1.4
Sources per story
1.5

Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 49 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering U.S. Department of Justice. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning U.S. Department of Justice 2

Funding Negative

White House keyword screening killed $2B in UC biomedical grants

The Trump administration's use of keyword filters to cancel nearly $2 billion in UC research grants dealt a heavy blow to biomedical innovation, affecting studies from gene therapy to clinical trials. The legal admission exposes the unscientific basis for the terminations.

2 sources

U.S. Department of Justice is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.